Thyroid, antibiotic drugs face fresh safety warnings after national review

New safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential mental health side effects for doxycycline. Carbimazole will now carry stronger warnings about a rare but serious blood disorder. Manufacturers must update prescribing information. These changes aim to improve patient safety by highlighting important risks.